Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/22219
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Baqar, Sara | - |
dc.contributor.author | Kong, Yee Wen | - |
dc.contributor.author | Chen, Angela X | - |
dc.contributor.author | O'Callaghan, Christopher J | - |
dc.contributor.author | Macisaac, Richard J | - |
dc.contributor.author | Bouterakos, Maree | - |
dc.contributor.author | Lambert, Gavin W | - |
dc.contributor.author | Jerums, George | - |
dc.contributor.author | Lambert, Elisabeth E | - |
dc.contributor.author | Ekinci, Elif I | - |
dc.date | 2019-11-25 | - |
dc.date.accessioned | 2019-12-04T05:00:32Z | - |
dc.date.available | 2019-12-04T05:00:32Z | - |
dc.date.issued | 2020-04-01 | - |
dc.identifier.citation | The Journal of Clinical Endocrinology and Metabolism 2020; 105(4): dgz219 | en_US |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/22219 | - |
dc.description.abstract | To determine if sympathetic nervous system (SNS) activation and endothelial dysfunction contribute to these observations, we examined the effect of salt supplementation on these systems in people with T2D with habitual low sodium. We hypothesized that salt supplementation will lower SNS activity and improve endothelial function compared to placebo. Randomized, double blinded, placebo-controlled, cross-over trial. Tertiary referral diabetes outpatients clinic. Salt supplementation (100mmol NaCl/24h) or placebo for three weeks was administered. Compared to placebo, salt supplementation increased MSNA (burst frequency p= 0.047, burst incidence p=0.016) however RHI (p=0.24), AI (p=0.201), ABPM (systolic p=0.09, diastolic p=0.14) and HRV were unaffected. Salt supplementation improved baroreflex (slope p=0.026), lowered aldosterone (p=0.004) and in salt-resistant individuals there was a trend towards improved RHI (p=0.07). In people with T2D and low habitual sodium intake, salt supplementation increased SNS activity without altering endothelial function or blood pressure but improved baroreflex function, a predictor of cardiac mortality. Salt-resistant individuals trended towards improved endothelial function with salt supplementation. | en_US |
dc.language.iso | eng | - |
dc.subject | endothelial dysfunction | en_US |
dc.subject | renin-angiotensin-aldosterone system | en_US |
dc.subject | salt sensitivity | en_US |
dc.subject | sympathetic nervous system | en_US |
dc.subject | twenty-four-hour urinary sodium excretion | en_US |
dc.subject | type two diabetes | en_US |
dc.title | Effect of salt supplementation on sympathetic activity and endothelial function in salt sensitive type 2 diabetes. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | The Journal of Clinical Endocrinology and Metabolism | en_US |
dc.identifier.affiliation | Endocrinology | en_US |
dc.identifier.affiliation | General Medicine | en_US |
dc.identifier.affiliation | Department of Endocrinology & Diabetes, St Vincent's Hospital, Melbourne, Australia | en_US |
dc.identifier.affiliation | Department of Medicine, The University of Melbourne, Victoria, Australia | en_US |
dc.identifier.affiliation | Clinical Pharmacology and Therapeutics | en_US |
dc.identifier.affiliation | Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia | en_US |
dc.identifier.affiliation | Iverson Health Innovation Research Institute and Faculty of Health, Arts and Design, Swinburne University of Technology, Victoria, Australia | en_US |
dc.identifier.doi | 10.1210/clinem/dgz219 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0002-4921-1349 | en_US |
dc.identifier.orcid | 0000-0003-2372-395X | en_US |
dc.identifier.pubmedid | 31761946 | - |
dc.type.austin | Journal Article | - |
local.name.researcher | Ekinci, Elif I | |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Clinical Pharmacology and Therapeutics | - |
crisitem.author.dept | Endocrinology | - |
crisitem.author.dept | Endocrinology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.